Peripheral Arterial Disease Trial, Recruiting NCT06082466 Sponsor: Paracelsus Medical University Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT06082466
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who are willing and able to sign a consent form agreeing to take part in the trial
  • People who have significant leg pain when walking short distances (less than 200 metres) due to poor blood flow, or who have more severe conditions such as rest pain, ulcers, or tissue loss in the leg caused by reduced blood supply
  • People who have suitable blood vessels available to support the planned procedure, both feeding into and receiving blood flow at the treatment site

Who may not be able to join:

  • Women who are pregnant or breastfeeding
  • People who currently have an active infection or widespread infection in the body (sepsis)
  • People experiencing a sudden, severe loss of blood flow to a limb (acute ischemia)
  • People who have recently had a procedure using a catheter or small instruments inside the blood vessel in the area planned for treatment
  • People whose vein (to be used in the procedure) measures less than 3.5 mm or more than 8 mm in outer width when measured under pressure
  • People whose vein has been joined together from multiple segments (spliced veins)
  • People with a known allergy to the metal alloy cobalt-chromium (ASTM 1058) or any of its components, including cobalt, chromium, iron, nickel, or molybdenum
  • People with vasculitis, which is inflammation of the blood vessels
  • People with a condition that affects the blood's ability to clot normally (coagulopathy)
  • People who have had radiation therapy close to the area where the blood vessel connection for this procedure would be made

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Stephan Koter, MD, PD, Senior Physician

Phone: +43 572550 57506

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Paracelsus Medical University
Registry
ClinicalTrials.gov
Start date
11 September 2023
Est. completion
1 September 2025

Where this trial is recruiting

🇦🇹 Austria

Primary endpoints

Incidence of primary patency of the venous bypass

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov